Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Surgical Oncology
|
March 24, 2012
Forward for translation research seminars
Alexander Stojadinovic, Martha Zeiger
The Surgical Clinics of North America
|
May 18, 2004
Extent of surgery for differentiated thyroid cancer
Alan P B Dackiw, Martha Zeiger
The Journal of Surgical Research
|
February 21, 2026
Coaching for Personal and Professional Development in Academic Surgery: A Conceptual Framework
Abbey Fingeret, Jayme Dowdall, Lisa M Reid, et al.
The Laryngoscope
|
February 4, 2005
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
Zayna Nahas, David Goldenberg, Carol Fakhry, et al.
Genome Medicine
|
September 6, 2014
Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors
Winston Timp, Hector Corrada Bravo, Oliver G McDonald, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 22, 2008
Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan
Emad Kandil, Anthony P Tufaro, Kathryn A Carson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2009
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer
Mingzhao Xing, Douglas Clark, Haixia Guan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2013
DNA copy number variations characterize benign and malignant thyroid tumors
Yan Liu, Leslie Cope, Wenyue Sun, et al.
Epigenetics
|
June 15, 2012
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
Mariana Brait, Myriam Loyo, Eli Rosenbaum, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 23, 2022
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
Dipranjan Laha, Robert R C Grant, Prachi Mishra, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Surgical Oncology
|
March 24, 2012
Forward for translation research seminars
Alexander Stojadinovic, Martha Zeiger
The Surgical Clinics of North America
|
May 18, 2004
Extent of surgery for differentiated thyroid cancer
Alan P B Dackiw, Martha Zeiger
The Journal of Surgical Research
|
February 21, 2026
Coaching for Personal and Professional Development in Academic Surgery: A Conceptual Framework
Abbey Fingeret, Jayme Dowdall, Lisa M Reid, et al.
The Laryngoscope
|
February 4, 2005
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
Zayna Nahas, David Goldenberg, Carol Fakhry, et al.
Genome Medicine
|
September 6, 2014
Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors
Winston Timp, Hector Corrada Bravo, Oliver G McDonald, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 22, 2008
Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan
Emad Kandil, Anthony P Tufaro, Kathryn A Carson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 6, 2009
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer
Mingzhao Xing, Douglas Clark, Haixia Guan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2013
DNA copy number variations characterize benign and malignant thyroid tumors
Yan Liu, Leslie Cope, Wenyue Sun, et al.
Epigenetics
|
June 15, 2012
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
Mariana Brait, Myriam Loyo, Eli Rosenbaum, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 23, 2022
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
Dipranjan Laha, Robert R C Grant, Prachi Mishra, et al.
Page
of 2